Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
118 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
PHARMAMED from Anderlecht, company number BE0444844572, closed financial year 2025 with a result of € 186,710 after tax. For that financial year PHARMAMED recorded a gross margin of € 532,003 and equity of € 439,425. Compared with financial year 2024, the result moved from € 127,432 to € 186,710. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 5, 2026.
€ 439,425
▲ 9% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 186,710
▲ 47% vs 2024
Profit after tax over the fiscal year.
€ 410,981
▲ 59% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 150,000 paid out
80 % of the profit went to the shareholders, mostly to MEDISOLUTIONS (100 % of the shares). That is where the money ends up.
People and assets in 2025
6.2
▲ 1.8 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 258,949
▲ 27% vs 2024
€ 41,800 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 105,125
▼ 20% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 29,070
▼ 42% vs 2024
€ 16,201 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 735,714
▲ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 77,526
▲ 11% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 556,093 | € 333,888 | € 408,778 | € 532,003 | ▲ 30% |
| Profit after taxes | € 141,056 | € 35,614 | € 127,432 | € 186,710 | ▲ 47% |
| Equity | € 369,670 | € 375,284 | € 402,716 | € 439,425 | ▲ 9% |
| Total debts | € 601,778 | € 748,966 | € 923,438 | € 1,007,245 | ▲ 9% |
| Cash | € 282,410 | € 183,300 | € 258,589 | € 410,981 | ▲ 59% |
| Retained profit | € 307,670 | € 313,284 | € 340,716 | € 377,425 | ▲ 11% |
| Dividend | € 100,000 | € 30,000 | € 100,000 | € 150,000 | ▲ 50% |
| Bank debt | € 32,763 | € 70,560 | € 50,085 | € 29,070 | ▼ 42% |
| Balance sheet total | € 971,448 | € 1,124,250 | € 1,326,154 | € 1,446,671 | ▲ 9% |
| Employees (FTE) | 4 | 4.1 | 4.4 | 6.2 | ▲ 1.8 |
Key figures of PHARMAMED, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMAMED?
What happened at PHARMAMED in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 186,710 (▲ 47% vs 2024). Source: NBB ↗
- MEDISOLUTIONS SRL became a director. NBB
- New establishment in Leuze-en-Hainaut. KBO
- Start of the company according to the CBE. KBO
In short
From € 141,056 profit in 2022 to € 186,710 profit in 2025.
Paid € 61,654 in corporate taxes since 2022.
Best year ever: 2025, with € 186,710 profit.
On average € 85,800 of value added per employee in 2025.
A new publication or filing at PHARMAMED? We notify you, reason included.
Follow PHARMAMEDDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of MEDISOLUTIONS comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMAMEDBehind PHARMAMED is MEDISOLUTIONS SRL. The shares are held by MEDISOLUTIONS (100%).
Directors
According to the 2025 annual accounts
Director · represented by Bruno GLORIEUX
since 2023
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Dokter Lemoinelaan 11 box 4
1070 Anderlecht
Rue du Développement durable(L) 24
7900 Leuze-en-Hainaut
Active since 18 December 1992
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 118 companies are registered at this address.
All companies at this address →Maât SRL
€ 5,760 gross margin · 2025
SAMSON BRUSH AND ABRASIVE TECHNOLOGY
€ -5,721 gross margin · 2025
ADJECTIF
€ 946 gross margin · 2022
RMC TOITURE
€ 94,486 gross margin · 2025
DACOSTA
+113 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Google Workspace
Hosting
CBLUE-AS, BE
Website info
Features
Security
Details
- Company number
- 0444.844.572
- VAT number
- BE 0444.844.572
- Registered office
- Dokter Lemoinelaan 11 bus 4, 1070 Anderlecht
- Names & denominations
- PHARMAMED
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 2 August 1991
- Peppol
- Active · Active since 15 Oct 2025
- Contact
- pharmamed.be [email protected] 068646045
- Activities · NACE
Groothandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen